Fisher Marlena C, Chen Xiaomeng, Crews Deidra C, DeGroot Lyndsay, Eneanya Nwamaka D, Ghildayal Nidhi, Gold Marshall, Liu Yi, Sanders Justin J, Scherer Jennifer S, Segev Dorry L, McAdams-DeMarco Mara A
Johns Hopkins School of Nursing, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Am J Kidney Dis. 2024 Mar;83(3):318-328. doi: 10.1053/j.ajkd.2023.07.018. Epub 2023 Sep 20.
RATIONALE & OBJECTIVE: Because of the high risk of waitlist mortality and posttransplant complications, kidney transplant (KT) patients may benefit from advance care planning (ACP) and palliative care consultation (PCC). We quantified the prevalence and racial disparities in ACP and PCC among KT candidates and recipients.
Prospective cohort study.
SETTING & PARTICIPANTS: 2,575 adult KT candidates and 1,233 adult recipients (2008-2020).
Race and ethnicity.
All reports of ACP and PCC were abstracted from chart review. ACP was defined as patient self-report of an advance directive, presence of an advance directive in the medical record, or a documented goals-of-care conversation with a provider. PCC was defined as an ordered referral or a documented palliative care note in the medical record.
Racial/ethnic disparities in ACP/PCC were estimated using adjusted logistic regression.
21.4% of KT candidates and 34.9% of recipients engaged in ACP. There were racial/ethnic disparities in ACP among KT candidates (White, 24.4%; Black, 19.1%; Hispanic, 15%; other race and ethnicity, 21.1%; P=0.008) and recipients (White, 39.5%; Black, 31.2%; Hispanic, 26.3%; other race and ethnicity, 26.6%; P=0.007). After adjustment, Black KT recipients had a 29% lower likelihood of engaging in ACP (OR, 0.71; 95% CI, 0.55-0.91) than White KT recipients. Among older (aged≥65 years) recipients, those who were Black had a lower likelihood of engaging in ACP, but there was no racial disparity among younger recipients (P=0.020 for interaction). 4.2% of KT candidates and 5.1% of KT recipients engaged in PCC; there were no racial disparities in PCC among KT candidates (White, 5.3%; Black, 3.6%; Hispanic, 2.5%; other race and ethnicity, 2.1%; P=0.13) or recipients (White, 5.5%; Black, 5.6%; Hispanic, 0.0%; other race and ethnicity, 1.3%; P = 0.21).
Generalizability may be limited to academic transplant centers.
ACP is not common among KT patients, and minoritized transplant patients are least likely to engage in ACP; PCC is less common. Future efforts should aim to integrate ACP and PCC into the KT process.
PLAIN-LANGUAGE SUMMARY: Kidney transplant (KT) candidates and recipients are at elevated risk of morbidity and mortality. They may benefit from completing a document or conversation with their palliative care provider that outlines their future health care wishes, known as advance care planning (ACP), which is a component of palliative care consultation (PCC). We wanted to determine how many KT candidates and recipients have engaged in ACP or PCC and identify potential racial disparities. We found that 21.4% of candidates and 34.9% of recipients engaged in ACP. After adjustment, Black recipients had a 29% lower likelihood of engaging in ACP. We found that 4.2% of KT candidates and 5.1% of KT recipients engaged in PCC, with no racial disparities found in PCC.
由于等待名单上的死亡风险和移植后并发症风险较高,肾移植(KT)患者可能会从预先护理计划(ACP)和姑息治疗咨询(PCC)中受益。我们对KT候选者和接受者中ACP和PCC的患病率及种族差异进行了量化。
前瞻性队列研究。
2575名成年KT候选者和1233名成年接受者(2008 - 2020年)。
种族和民族。
所有关于ACP和PCC的报告均从病历审查中提取。ACP被定义为患者自我报告有预先指示、病历中有预先指示,或与医疗服务提供者进行过记录在案的医疗护理目标谈话。PCC被定义为医嘱转诊或病历中有记录的姑息治疗记录。
使用调整后的逻辑回归估计ACP/PCC中的种族/民族差异。
21.4%的KT候选者和34.9%的接受者参与了ACP。KT候选者(白人,24.4%;黑人,19.1%;西班牙裔,15%;其他种族和民族,21.1%;P = 0.008)和接受者(白人,39.5%;黑人,31.2%;西班牙裔,26.3%;其他种族和民族,26.6%;P = 0.007)中存在ACP方面的种族/民族差异。调整后,黑人KT接受者参与ACP的可能性比白人KT接受者低29%(比值比,0.71;95%置信区间,0.55 - 0.91)。在年龄较大(≥65岁)的接受者中,黑人参与ACP的可能性较低,但年轻接受者中不存在种族差异(交互作用P = 0.020)。4.2%的KT候选者和5.1%的KT接受者参与了PCC;KT候选者(白人,5.3%;黑人,3.6%;西班牙裔,2.5%;其他种族和民族,2.1%;P = 0.13)或接受者(白人,5.5%;黑人,5.6%;西班牙裔,0.0%;其他种族和民族,1.3%;P = 0.21)中PCC不存在种族差异。
普遍性可能仅限于学术移植中心。
ACP在KT患者中并不常见,少数族裔移植患者参与ACP的可能性最小;PCC则更不常见。未来的努力应旨在将ACP和PCC纳入KT流程。
肾移植(KT)候选者和接受者发病和死亡风险较高。他们可能会从与姑息治疗提供者完成一份文件或进行一次谈话中受益,该文件或谈话概述了他们未来的医疗护理愿望,即预先护理计划(ACP),这是姑息治疗咨询(PCC)的一个组成部分。我们想确定有多少KT候选者和接受者参与了ACP或PCC,并识别潜在的种族差异。我们发现21.4%的候选者和34.9%的接受者参与了ACP。调整后,黑人接受者参与ACP的可能性低29%。我们发现4.2%的KT候选者和5.1%的KT接受者参与了PCC,PCC中未发现种族差异。